bromocriptine has been researched along with Argentaffinoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colato, C; Davì, MV; Ferdeghini, M; Francia, G; Lo Cascio, V; Montresor, E | 1 |
| Adams, EF; Ashby, MJ; Brown, SM; Mashiter, K; White, MC | 1 |
| Bathija, PJ; Monnot, EA; Reith, P | 1 |
3 other study(ies) available for bromocriptine and Argentaffinoma
| Article | Year |
|---|---|
Long-term quiescence of ectopic Cushing's syndrome caused by pulmonary neuroendocrine tumor (typical carcinoid) and tumorlets: spontaneous remission or therapeutic effect of bromocriptine?
Topics: ACTH Syndrome, Ectopic; Bromocriptine; Carcinoid Tumor; Cushing Syndrome; Female; Humans; Lung Neoplasms; Middle Aged; Neoplasm Regression, Spontaneous | 2006 |
Bromocriptine suppresses ACTH secretion from human pituitary tumour cells in culture by a dopaminergic mechanism.
Topics: Adenoma; Adrenocorticotropic Hormone; Adult; Bromocriptine; Carcinoid Tumor; Cells, Cultured; Dopamine; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Lung Neoplasms; Male; Pituitary Neoplasms | 1981 |
Prolonged suppression of a corticotropin-producing bronchial carcinoid by oral bromocriptine.
Topics: Administration, Oral; Adrenocorticotropic Hormone; Adult; Bromocriptine; Bronchial Neoplasms; Carcinoid Tumor; Female; Humans | 1987 |